BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38658552)

  • 1. High clonal diversity and spatial genetic admixture in early prostate cancer and surrounding normal tissue.
    Zhang N; Harbers L; Simonetti M; Diekmann C; Verron Q; Berrino E; Bellomo SE; Longo GMC; Ratz M; Schultz N; Tarish F; Su P; Han B; Wang W; Onorato S; Grassini D; Ballarino R; Giordano S; Yang Q; Sapino A; Frisén J; Alkass K; Druid H; Roukos V; Helleday T; Marchiò C; Bienko M; Crosetto N
    Nat Commun; 2024 Apr; 15(1):3475. PubMed ID: 38658552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
    Chen Y; Sadasivan SM; She R; Datta I; Taneja K; Chitale D; Gupta N; Davis MB; Newman LA; Rogers CG; Paris PL; Li J; Rybicki BA; Levin AM
    BMC Med Genomics; 2020 Aug; 13(1):116. PubMed ID: 32819446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of abnormal diploid DNA histograms in localized prostate cancer and adjacent benign prostatic tissue.
    Deitch AD; Miller GJ; deVere White RW
    Cancer; 1993 Sep; 72(5):1692-700. PubMed ID: 7688657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.
    Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S
    Cells; 2020 Aug; 9(8):. PubMed ID: 32784507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA ploidy measured on archived pretreatment biopsy material may correlate with prostate-specific antigen recurrence after prostate brachytherapy.
    Keyes M; Macaulay C; Hayes M; Korbelik J; Morris WJ; Palcic B
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):829-34. PubMed ID: 23688814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of DNA ploidy in carcinoma of prostate.
    Dejter SW; Cunningham RE; Noguchi PD; Jones RV; Moul JW; McLeod DG; Lynch JH
    Urology; 1989 May; 33(5):361-6. PubMed ID: 2711553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatially resolved clonal copy number alterations in benign and malignant tissue.
    Erickson A; He M; Berglund E; Marklund M; Mirzazadeh R; Schultz N; Kvastad L; Andersson A; Bergenstråhle L; Bergenstråhle J; Larsson L; Alonso Galicia L; Shamikh A; Basmaci E; Díaz De Ståhl T; Rajakumar T; Doultsinos D; Thrane K; Ji AL; Khavari PA; Tarish F; Tanoglidi A; Maaskola J; Colling R; Mirtti T; Hamdy FC; Woodcock DJ; Helleday T; Mills IG; Lamb AD; Lundeberg J
    Nature; 2022 Aug; 608(7922):360-367. PubMed ID: 35948708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer.
    Frankfurt OS; Chin JL; Englander LS; Greco WR; Pontes JE; Rustum YM
    Cancer Res; 1985 Mar; 45(3):1418-23. PubMed ID: 3971384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.
    Su F; Zhang W; Zhang D; Zhang Y; Pang C; Huang Y; Wang M; Cui L; He L; Zhang J; Zou L; Zhang J; Li W; Li L; Shao J; Ma J; Xiao F; Liu M
    Eur Urol; 2018 Nov; 74(5):551-559. PubMed ID: 29941308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection toward diploid cells in prostatic carcinoma derived cell cultures.
    Ketter R; Zwergel T; Romanakis K; Unteregger G; Ziegler M; Zang KD; Wullich B
    Prostate; 1996 Jun; 28(6):364-71. PubMed ID: 8650073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy.
    Pollack A; Zagars GK; el-Naggar AK; Gauwitz MD; Terry NH
    Cancer; 1994 Apr; 73(7):1895-903. PubMed ID: 7511039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of genetic alterations associated with DNA diploidy, aneuploidy and multiploidy in gastric cancers.
    Sugai T; Habano W; Jiao YF; Suzuki M; Takagane A; Nakamura S
    Oncology; 2005; 68(4-6):548-57. PubMed ID: 16037688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aneuploidy of chromosome 9 and the tumor suppressor genes p16(INK4) and p15(INK4B) detected by in situ hybridization in locally advanced prostate cancer.
    Heidenreich B; Heidenreich A; Sesterhenn A; Srivastava S; Moul JW; Sesterhenn IA
    Eur Urol; 2000 Oct; 38(4):475-82. PubMed ID: 11025389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The landscape of somatic chromosomal copy number aberrations in GEM models of prostate carcinoma.
    Bianchi-Frias D; Hernandez SA; Coleman R; Wu H; Nelson PS
    Mol Cancer Res; 2015 Feb; 13(2):339-47. PubMed ID: 25298407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.
    Camacho N; Van Loo P; Edwards S; Kay JD; Matthews L; Haase K; Clark J; Dennis N; Thomas S; Kremeyer B; Zamora J; Butler AP; Gundem G; Merson S; Luxton H; Hawkins S; Ghori M; Marsden L; Lambert A; Karaszi K; Pelvender G; Massie CE; Kote-Jarai Z; Raine K; Jones D; Howat WJ; Hazell S; Livni N; Fisher C; Ogden C; Kumar P; Thompson A; Nicol D; Mayer E; Dudderidge T; Yu Y; Zhang H; Shah NC; Gnanapragasam VJ; ; Isaacs W; Visakorpi T; Hamdy F; Berney D; Verrill C; Warren AY; Wedge DC; Lynch AG; Foster CS; Lu YJ; Bova GS; Whitaker HC; McDermott U; Neal DE; Eeles R; Cooper CS; Brewer DS
    PLoS Genet; 2017 Sep; 13(9):e1007001. PubMed ID: 28945760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors.
    Zincke H; Bergstralh EJ; Larson-Keller JJ; Farrow GM; Myers RP; Lieber MM; Barrett DM; Rife CC; Gonchoroff NJ
    Cancer; 1992 Jul; 70(1 Suppl):311-23. PubMed ID: 1600493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of DNA-ploidy and S-phase fraction in node-positive (stage D1) prostate cancer treated with androgen ablation.
    Pollack A; Troncoso P; Zagars GK; von Eschenbach AC; Mak AC; Wu CS; Terry NH
    Prostate; 1997 Apr; 31(1):21-8. PubMed ID: 9108882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic copy number alterations by whole-exome sequencing implicates YWHAZ and PTK2 in castration-resistant prostate cancer.
    Menon R; Deng M; Rüenauver K; Queisser A; Peifer M; Pfeifer M; Offermann A; Boehm D; Vogel W; Scheble V; Fend F; Kristiansen G; Wernert N; Oberbeckmann N; Biskup S; Rubin MA; Adler D; Perner S
    J Pathol; 2013 Dec; 231(4):505-16. PubMed ID: 24114522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of EpCAM
    Liu M; Di J; Liu Y; Su Z; Jiang B; Wang Z; Su X
    Cancer Biol Ther; 2018; 19(10):939-947. PubMed ID: 29580161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel near-diploid ovarian cancer cell line derived from a highly aneuploid metastatic ovarian tumor.
    Rozenblum E; Sotelo-Silveira JR; Kim GY; Zhu JY; Lau CC; McNeil N; Korolevich S; Liao H; Cherry JM; Munroe DJ; Ried T; Meltzer PS; Kuehl WM; Roschke AV
    PLoS One; 2017; 12(8):e0182610. PubMed ID: 28787462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.